Roche Q3 Results - Q3 Top Pharma Company Earnings Reports
View Roche's Q3 Earnings Report
Highlights:
- Group sales up 3.1 billion to 36.4 billion Swiss francs in first nine months, an increase of 11% in local currencies (9% in Swiss francs); both divisions grow significantly faster than their respective markets
- Genentech integration progressing successfully
- New Group leadership appointed
Check out Roche's current earnings estimates from CNN Money
Roche's Website: http://www.roche.com/
Related Articles:
Roche diabetes drug beats Byetta
Roche hiring for research campus
Schwan plans to scrutinize Genentech pay
SurModics shares surge on $200M Roche pact
Roche reshuffles management in biotech makeover
More stories about Roche
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: